Toxicity and Local Tolerance of a Novel Spike Protein RBD Vaccine Against SARS-CoV-2, Produced Using the C1 <i>Thermothelomyces Heterothallica</i> Protein Expression Platform.

Ramot, Yuval; Kronfeld, Noam; Ophir, Yakir; Ezov, Nati; Friedman, Sheli; Saloheimo, Markku; Vitikainen, Marika; Ben-Artzi, Hanna; Avigdor, Avi; Tchelet, Ronen; Valbuena Crespo, Noelia; Emalfarb, Mark; Nyska, Abraham

Toxicity and Local Tolerance of a Novel Spike Protein RBD Vaccine Against SARS-CoV-2, Produced Using the C1 Thermothelomyces Heterothallica Protein Expression Platform.

Ramot, Yuval; Kronfeld, Noam; Ophir, Yakir; Ezov, Nati; Friedman, Sheli; Saloheimo, Markku; Vitikainen, Marika; Ben-Artzi, Hanna; Avigdor, Avi; Tchelet, Ronen; Valbuena Crespo, Noelia; Emalfarb, Mark; Nyska, Abraham.

Afiliación

Ramot Y; The Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
Kronfeld N; Department of Dermatology, Hadassah Medical Center, Jerusalem, Israel.
Ophir Y; Envigo CRS Israel Limited, Ness Ziona, Israel.
Ezov N; Israel Institute for Biological Research, Ness Ziona, Israel.
Friedman S; Envigo CRS Israel Limited, Ness Ziona, Israel.
Saloheimo M; Envigo CRS Israel Limited, Ness Ziona, Israel.
Vitikainen M; Technical Research Centre of Finland Ltd., Espoo, Finland.
Ben-Artzi H; Technical Research Centre of Finland Ltd., Espoo, Finland.
Avigdor A; BTG-Biotechnology General (Israel) Ltd., Kiryat Malachi, Israel.
Tchelet R; BTG-Biotechnology General (Israel) Ltd., Kiryat Malachi, Israel.
Valbuena Crespo N; Dyadic International, Inc., Jupiter, Florida, USA.
Emalfarb M; Dyadic International, Inc., Jupiter, Florida, USA.
Nyska A; Dyadic International, Inc., Jupiter, Florida, USA.

Toxicol Pathol ; 50(3): 294-307, 2022 04.

Article en En | MEDLINE | ID: mdl-35514116

Asunto(s)

COVID-19; SARS-CoV-2; Animales; COVID-19/prevención & control; Vacunas contra la COVID-19; Humanos; Pandemias/prevención & control; Conejos; Glicoproteína de la Espiga del Coronavirus/química; Glicoproteína de la Espiga del Coronavirus/metabolismo

Palabras clave

C1; COVID-19; RBD; SARS-CoV-2; Thermothelomyces heterothallica; rabbits; safety; toxicity; vaccine

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Límite: Animals / Humans Idioma: En Revista: Toxicol Pathol Año: 2022 Tipo del documento: Article País de afiliación: Israel

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google